kindly summarize this introduction "Pharmaceutical packaging is a USD 70 billion global industry with an estimated 6% year-over-year CAGR [1]. Medicine, unlike other packaging categories, is still in demand, and the market is even more essential now, as the COVID-19 pandemic has reached a critical stage. Pharmaceutical packaging protects medicines from contamination, damage, deteriora- tion and counterfeiting, alongside extending product shelf life. International regulatory bodies have implored drug and packaging manufacturers to play a critical role in the drug supply chain. Plastics are the most popular material used in the packaging industry [2]. Plastic belongs to one class of polymer known as thermoplastics, which has a range of different properties. The structures of thermoplastics enable polymer chains to move freely, to change forms as a function of temperature [3]. For example, polyethylene, polystyrene, polyvinyl chloride and polypropylene are the common polymers manipulated in the preparation of plastic containers of various densities to fit specific formulation needs. Growth in the pharmaceutical packaging market is attributed to increased R&D, gener- ics, innovative packaging materials and increased outsourcing to contract packagers. Plastic bottles, parenteral containers, blister packaging, specialty bags, closures, labels and other products are in massive demand in the pharmaceutical industry. However